We are a premier vector technology CRO that specializes in superior viral and non-viral payload delivery solutions.
Connect With UsCARGO is Carrigent’s patent-pending technology that offers increased loading capacity, cell-specific targeting and reduced systemic toxicity.
See Our Approach
Carrigent's aim is to solve the challenges of high cost, low targeting specificity, and packaging limitations associated with typical viral vectors through novel viral and non-viral delivery platforms.
Get to Know UsCarrigent offers a range of contract services to support better payload delivery. From plasmid optimization to vector design, cell line development, gene editing, preclinical viral production, and technology licensing, we can help bring next-generation vector technologies to your therapeutic asset.
Learn More
© Carrigent 2025. All Rights Reserved.
